BILIFALK Trademark

Trademark Overview

On Wednesday, July 31, 2013, a trademark application was filed for BILIFALK with the United States Patent and Trademark Office. The USPTO has given the BILIFALK trademark a serial number of 86025219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 8, 2017. This trademark is owned by Dr. Falk Pharma GmbH. The BILIFALK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the dissolution of cholesterol gallstones in the gallbladder, for the treatment of biliary reflux gastritis, of cholestatic liver diseases and of cystic fibrosis associated liver disease
bilifalk

General Information

Serial Number86025219
Word MarkBILIFALK
Filing DateWednesday, July 31, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 8, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the dissolution of cholesterol gallstones in the gallbladder, for the treatment of biliary reflux gastritis, of cholestatic liver diseases and of cystic fibrosis associated liver disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 8, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDr. Falk Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFreiburg D-79108
DE
Party NameDr. Falk Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFreiburg D-79108
DE

Trademark Events

Event DateEvent Description
Monday, May 8, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 8, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 26, 2016EXTENSION 5 GRANTED
Wednesday, August 17, 2016EXTENSION 5 FILED
Wednesday, August 17, 2016TEAS EXTENSION RECEIVED
Wednesday, March 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 1, 2016EXTENSION 4 GRANTED
Thursday, February 18, 2016EXTENSION 4 FILED
Thursday, February 18, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 3 GRANTED
Wednesday, August 5, 2015EXTENSION 3 FILED
Wednesday, August 5, 2015TEAS EXTENSION RECEIVED
Thursday, March 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 11, 2015EXTENSION 2 GRANTED
Thursday, January 22, 2015EXTENSION 2 FILED
Tuesday, March 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 22, 2015TEAS EXTENSION RECEIVED
Wednesday, July 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2014EXTENSION 1 GRANTED
Monday, June 30, 2014EXTENSION 1 FILED
Monday, June 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 30, 2013ASSIGNED TO LIE
Tuesday, December 24, 2013ASSIGNED TO LIE
Monday, December 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 23, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 22, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 22, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 14, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 14, 2013LETTER OF SUSPENSION E-MAILED
Thursday, November 14, 2013SUSPENSION LETTER WRITTEN
Thursday, November 14, 2013ASSIGNED TO EXAMINER
Thursday, August 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 3, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

bilifalk liver diseases cholestatic cystic fibrosis disease associated gastritis reflux cholesterol